San Jose's new biotech incubator: BioCube North

“Our objective is be a launchpad for the next wave of biotech success stories,” said Oscar Battaglia, who will oversee the new wet lab spaces.

“Our objective is be a launchpad for the next wave of biotech success stories,” said Oscar Battaglia, who will oversee the new wet lab spaces.

Biotech sprouts new shoots in Silicon Valley

While most of the biggest tech companies are located in Silicon Valley, biotech’s center of gravity is located some 20 miles north. That may be changing as a new wave of budding biotech companies now have a good reason to locate closer to San Jose.

San Jose BioCube, an established life-sciences incubator, has just announced the availability of 15 move-in-ready wet labs designed for high-potential life sciences startups. Dubbed “BioCube North,” the incubator is housed on the ground floor of the Q Bay Center, the 112,232-square-foot facility at 160 East Tasman Drive in San Jose.

With a multi-billion-dollar track record of nurturing nascent startups and supporting scores of commercialized discoveries, BioCube continues to foster next waves of great ideas that will rival past graduate disruptors such as Impossible Foods, Ariosa Diagnostics (acquired by Roche), Collagen Solutions (AIM: COS), Genia Technologies (acquired by Roche), Aridis Pharmaceuticals (NAS: ARDS), and Geneweave (acquired by Roche).

“The San Francisco Bay Area is a top science and research hub because there are three major universities and scores of global companies that attract top scientists and technicians from around the world,” said Oscar Battaglia, director of operations at BioCube San Jose. “Our objective is to provide access to all this talent and a launchpad for the next wave of biotech, cleantech, and life-sciences success stories.”

Securing coverage for BioCube’s announcement

Tim Cox of ZingPR worked closely with Jane Lalonde of MatchCMO (ZingPR’s favorite design and creative guru) to plan and execute a launch strategy. Given the dearth of San Jose biotech news, we decided this was a perfect story for the Silicon Valley Business Journal — specifically its lead tech writer, Cromwell Schubarth.

Cromwell interviewed BioCube Managing Director Tony Gonzalez and published a thorough and informative article that will certainly catch the attention of local VCs and startups in the biotech sector.


Previous
Previous

rBIO aims to reduce the cost of insulin by 30%

Next
Next

AIStorm snags $16M Series B to add AI to tiny sensors